SWOG clinical trial number
SWOG-7431
Methyl CCNU - Adriamycin (MAP) for patients with Metastatic Sarcoma Refractory to Actinomycin D and/or Cyclophosphamide
Closed
Abbreviated Title
Methyl CCNU - Adriamycin (MAP) for patients with Metastatic Sarcoma Refractory to Actinomycin D and/or Cyclophosphamide
Activated
11/06/1974
Closed
10/21/1976
Publication Information Expand/Collapse
1980
Methyl-CCNU and Adriamycin for patients with metastatic sarcomas: A Southwest Oncology Group study.